Chemotherapy-induced recruitment of myeloid-derived suppressor cells abrogates efficacy of immune checkpoint blockade

Kwong, TT; Wong, CH; Zhou, JY; Cheng, ASL; Sung, JJY; Chan, AWH; Chan, SL

Chan, SL (corresponding author), Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China.

JHEP REPORTS, 2021; 3 (2):

Abstract

Background & aims: Immune checkpoint blockade (ICB) has been approved for treatment of hepatocellular carcinoma (HCC). However, many patients with......

Full Text Link